Close Menu

    Subscribe to Updates

    Get the latest news information from worldwide businesses.

    What's Hot

    These New York City Secrets Will Put Your Knowledge to the Test

    June 10, 2026

    Viyash Scientific’s Alivira to Acquire Italy’s BioForLife for Rs 188 Crore, Expands Pet Care Business

    June 10, 2026

    The future of AI regulation is courting the strangest, most anxious bedfellows

    June 10, 2026
    Facebook Instagram YouTube LinkedIn X (Twitter)
    Trending
    • These New York City Secrets Will Put Your Knowledge to the Test
    • Viyash Scientific’s Alivira to Acquire Italy’s BioForLife for Rs 188 Crore, Expands Pet Care Business
    • The future of AI regulation is courting the strangest, most anxious bedfellows
    • Wing drone delivery might not be a novelty anymore
    • No overcapacity in steel, textiles; India’s consumption remains low: DGTR
    • RBI issues draft CCR framework aligned with global standards
    • The 4.2% inflation rate is a bummer, but the worst might be over
    • Credit guarantee scheme for MFI 2.0 gets extension
    Newspublicly
    • About Us
    • Advertise & Partner with us
    • Pitch Your Story
    • Contact Us
    Facebook Instagram LinkedIn X (Twitter)
    Subscribe
    • Home
    • World News
      • Asia
      • India
      • USA
      • UK & Europe
      • Middle East
    • Economy & Business
      • Global Economy
      • Corporate & Industry
      • Finance & Markets
      • Policy & Trade
    • Technology
      • Gadgets & Devices
      • Software & Apps
      • AI & Machine Learning
      • Robotics & Automation
    • Health & Medicine
      • Fitness & Nutrition
      • Research & Innovation
      • Disease & Treatment
      • Doctors, Clinics & Patient Care
    • Travel & Tourism
    • Automobile
      • Electric & Hybrid Vehicles
      • Auto Industry Insights
    • Sports
    • More
      • Education
      • Real Estate
      • Environment & Climate
      • Space & Astronomy
      • War & Conflicts
    Newspublicly
    Home»Technology»Gadgets & Devices»Fable won’t answer basic biology questions
    Gadgets & Devices

    Fable won’t answer basic biology questions

    AdminBy AdminJune 10, 2026No Comments4 Mins Read0 Views
    Share
    Facebook Twitter LinkedIn Copy Link WhatsApp


    Anthropic just released Claude Fable 5, calling it the most powerful AI model it has ever made widely available and praising its skills in biology, among others. But the model won’t answer basic biology questions — the kind you’d expect a high schooler to handle. Instead, it hands off the query to the former flagship model, Claude Opus 4.8.

    It isn’t because Fable doesn’t know the answers. It’s because Anthropic won’t let it, by design.

    Fable is a public-facing, Mythos-class model, a family so capable at cybersecurity tasks Anthropic said it was too dangerous to release publicly. But while Anthropic has spent much of the extended Mythos rollout warning about cybersecurity, it is biology where Fable’s guardrails are the most obvious — and most limiting.

    When I tried the model, it refused to answer a range of basic biology questions, many that felt about as far away from any plausible safety risk as any question could be. It would not respond to “tell me about cell membranes” or answer “what are mitochondria,” that famous powerhouse of the cell. It refused to explain “what is a prion,” the proteinaceous particles behind mad cow disease, or “how mRNA vaccines work.”

    “We made this tradeoff so customers could benefit from the model’s capabilities sooner without the risks.”

    The restrictions applied to ordinary and objectively rather harmless medical queries too. Fable would not answer “what causes hay fever,” explain how asthma medicine works, explain how antibiotic resistance arises, or tell me what Ebola is and how it spreads. Some of my basic queries occasionally got through, with Fable answering questions like “what is cancer” and “what is DNA.” When Fable refused, Opus 4.8 generally answered perfectly well.

    Anthropic says the broad biology filters are an intentional choice and are deliberately conservative, with bioweapons the primary concern. “With the launch of Claude Fable 5, our first Mythos-class model, we believe models now have a greater ability to accomplish real-world scientific tasks and for malicious actors to potentially use our models for highly risky biological research,” spokesperson Paruul Maheshwary told The Verge. “We have always used classifiers to block our models from helping with bioweapons-related requests. To deploy Fable 5 safely, we believe it was necessary to be overly conservative with our safeguards so they block most queries tied to biology work.”

    Anthropic has previously highlighted four key areas where it would throttle Fable’s responses for safety: chemistry, biology, cybersecurity, and distillation, a technique for training smaller AIs using the outputs of larger ones. The company has accused Chinese rivals like DeepSeek of using distillation on its models on an “industrial” scale.

    While I could not meaningfully test distillation, Fable seemed more willing to answer questions about chemistry and cybersecurity. For example, it gave a basic overview of the explosive TNT, though withheld synthesis instructions “for obvious reasons.” It readily answered questions on the use of chlorine gas as a chemical weapon, common password threats, and nuclear fusion and fission, as well as explaining how to secure an iPhone from hackers. It still limits: Fable deferred to Opus when I asked it about sarin gas, a highly toxic nerve agent. Fable and Opus both refused the prompt “how to make anthrax,” and Claude paused the chat entirely. That made sense. The mitochondria prompt refusal seems like a false positive.

    “We made this tradeoff so customers could benefit from the model’s capabilities sooner without the risks,” Maheshwary explained, adding that Anthropic is working hard to improve its detection and reduce the false positives. “We intend to make Mythos-class models available without these safeguards to the broader biology and life sciences community so these capabilities can be used to accelerate biomedical research and drug discovery.”

    Anthropic did not answer questions about whether this kind of restricted release will become the new norm for future models.

    Follow topics and authors from this story to see more like this in your personalized homepage feed and to receive email updates.

    • Robert Hart

      Robert Hart

      Robert Hart

      Posts from this author will be added to your daily email digest and your homepage feed.

      See All by Robert Hart

    • AI

      Posts from this topic will be added to your daily email digest and your homepage feed.

      See All AI

    • Anthropic

      Posts from this topic will be added to your daily email digest and your homepage feed.

      See All Anthropic

    • Report

      Posts from this topic will be added to your daily email digest and your homepage feed.

      See All Report

    • Science

      Posts from this topic will be added to your daily email digest and your homepage feed.

      See All Science



    Source link

    Author

    • Admin

      NewsPublicly.com is News & Articles Platform that creating SEO-focused articles on travel, lifestyle, and digital trends.

    Admin
    • Website

    NewsPublicly.com is News & Articles Platform that creating SEO-focused articles on travel, lifestyle, and digital trends.

    Related Posts

    The future of AI regulation is courting the strangest, most anxious bedfellows

    June 10, 2026

    Microsoft, like, totally gets why students are booing AI-pilled graduation speakers

    June 10, 2026

    Microsoft restricts Claude Fable for employees over data retention concerns

    June 10, 2026
    Leave A Reply Cancel Reply

    Demo
    Top Posts

    The Blue Moon rises on May 30— Where and when to see the second full moon of the month

    May 30, 202640 Views

    New SOCOM rifle allows barrel swapping and cartridge changes

    June 1, 202632 Views

    “Inside Gemini Robotics 1.5: How Robots Learn to Reason & Act

    November 22, 202525 Views

    525 pounds of cocaine seized after Nebraska K9 alerts troopers on I-80

    May 28, 202624 Views
    Don't Miss

    These New York City Secrets Will Put Your Knowledge to the Test

    June 10, 20261 Min Read0 Views

    How well do you think you know New York City secrets? It may be true…

    Viyash Scientific’s Alivira to Acquire Italy’s BioForLife for Rs 188 Crore, Expands Pet Care Business

    June 10, 2026

    The future of AI regulation is courting the strangest, most anxious bedfellows

    June 10, 2026

    Wing drone delivery might not be a novelty anymore

    June 10, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Instagram
    • YouTube
    • LinkedIn
    • WhatsApp

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    Demo
    NEWSPUBLICLY
    Facebook X (Twitter) Instagram LinkedIn

    Home

    • About Us
    • Leadership
    • Advertise & Partner With Us
    • Pitch Your Story
    • Media Kit & Pricing
    • Career
    • FAQs

    Guidelines

    • Editorial & Submission
    • Partnership
    • Advertising & Sponsor
    • Intellectual Property Policy
    • Community & Comment
    • Security & Data Protection
    • Send Your Opinion

    Quick Links

    • Cookie Policy
    • Payment & Billing Terms
    • Refund & Cancellation
    • Copyright Policy
    • Complaint & Support
    • Sitemap
    • Contact Us

    Subscribe Us

    Get the latest news and updates!

    Copyright © 2026 Newspublicly (DIGITALIX COMMUNICATION). All Rights Reserved.
    • Privacy Policy
    • Terms of Use
    • Disclaimer